Can-Fite BioPharma Ltd. (CANF) Operating income 2017–2025
Can-Fite BioPharma Ltd. (CANF) annual operating income history from SEC filings — each fiscal year as reported.
-$9.9MFY2025 · since FY2017: -$7.2M → -$9.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.9M | -22.4% |
| FY2024 | -$8.1M | +0.8% |
| FY2023 | -$8.2M | +18.8% |
| FY2022 | -$10.1M | +21.4% |
| FY2021 | -$12.8M | +9.2% |
| FY2020 | -$14.1M | -17.8% |
| FY2019 | -$12.0M | -121.8% |
| FY2018 | -$5.4M | +24.6% |
| FY2017 | -$7.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice